Pfizer press release misrepresented to stir up myocarditis controversy

On October 13, Pfizer released an update about Paxlovid and Comirnaty that included a safety note about myocarditis that appears on all releases related to the vaccine. Vaccine opponents are sharing screenshots of the note, insinuating that it is the first time the company has acknowledged the risk. Notably, most posts don’t link to the press release, where it is immediately clear that the note about myocarditis is part of standard safety language in pharmaceutical materials.

Recommendation: Medium Risk Read More +

Sign Up for Public Health Alerts

This field is for validation purposes and should be left unchanged.

About Us

The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans’ confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials.

Learn More

Recent Misinformation Alerts